Lantheus (NASDAQ:LNTH) is a dynamic player in the healthcare sector, specializing in diagnostic imaging and targeted therapeutics. The company is dedicated to advancing patient care through the development, manufacture, and commercialization of innovative diagnostic imaging agents and products that assist clinicians in diagnosing and treating cardiovascular and other diseases. Currently, Lantheus has a broad portfolio of products that are used by healthcare professionals around the world in medical imaging procedures. With a strong focus on strategic collaborations and research, Lantheus aims to enhance its existing product lineup and explore new therapeutic areas. Their objective is to improve patient outcomes and deliver value to their stakeholders by investing in growth areas and leveraging their expertise in medical imaging and targeted radiopharmaceuticals.